MedTrace Logo

Development and Validation of a Virtual Biopsy System in Kidney Transplant

NCT04759209 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12992

Last updated 2021-02-21

No results posted yet for this study

Summary

Currently, kidney allograft biopsies are routinely performed to determine diagnosis and prognosis of kidney allografts. The histological interpretation of these biopsies is based on the Banff consensus for renal allograft pathology. The purpose of this study is to provide to the physicians a reliable estimation of renal allograft lesions of the day zero biopsy (kidney donor biopsy performed before transplantation).

Conditions

  • Kidney Transplantation

Interventions

DIAGNOSTIC_TEST

Biopsies

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • KU Leuven

    collaborator OTHER

  • University of Liege

    collaborator OTHER

  • University of British Columbia

    collaborator OTHER

  • Hospital Clinic of Barcelona

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER

  • Hospital Vall d'Hebron

    collaborator OTHER

  • Hospital Universitari de Bellvitge

    collaborator OTHER

  • Clinical Hospital Centre Zagreb

    collaborator OTHER

  • University of Alberta

    collaborator OTHER

  • University of Adelaide

    collaborator OTHER

  • Paris Translational Research Center for Organ Transplantation

    lead OTHER

Principal Investigators

  • Alexandre Loupy · Paris Translational Research Center for Organ Transplantation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04759209 on ClinicalTrials.gov